AstraZeneca, AI Company Absci Partner to Find Cancer Cure
AstraZeneca, the pharmaceutical company that developed one of the COVID-19 vaccines, will collaborate with Absci, an artificial intelligence (AI) biologics company based in the United States, to develop a cancer antibody. The Financial Times reported on December 3 that AstraZeneca intends to allocate a maximum of $247 million towards research and development, milestone payments, and […]